(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

WUXIHIGH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

WUXIHIGH

ST13

US500000098033533

Class

40, 42

Filing

98033533

Registration

7415845

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

17

Latest update

06/11/2024

Trademark type

Combined

Nice classes

40, 42

Filing date

06/08/2023

Registration date

06/11/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/11/2024

Last transaction

06/11/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-04-00

First use in commerce

2023-04-00

Drawing code

3

Owner type

99

Owner location

DUNDALK, CO LOUTH, IE

Examiner

GEARHART, JESSICA

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word WuXiHigh with a syringe as part of the second "h".

Holders and representatives

Holders

WUXI BIOLOGICS IRELAND LIMITED

Representatives

Michael T. Smith BIRCH STEWART KOLASCH & BIRCH, LLP

Technical classification

Nice Classes

Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Custom manufacture of pharmaceuticals by pharmaceutical compounders; Custom manufacture of biopharmaceuticals by pharmaceutical compounders; Custom manufacture of nutraceuticals by pharmaceutical compounders; Custom manufacture of vitamins for humans

Class 42

Product development for others; pharmaceutical drug developments services; scientific research and development; pharmaceutical research; research and development of new products; consulting services in the field of pharmaceutical technology development; biochemical research and analysis; biomedical research services; development of pharmaceutical preparations and medicines; research and development of antibodies

Publications

History of USPTO decisions and trademark events.

17 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

06/11/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

06/11/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

05/07/2024

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

05/07/2024

SUPC

STATEMENT OF USE PROCESSING COMPLETE

02/29/2024

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

02/24/2024

IUAF

USE AMENDMENT FILED

02/05/2024

EISU

TEAS STATEMENT OF USE RECEIVED

02/05/2024

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/16/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/21/2023

PUBO

PUBLISHED FOR OPPOSITION

11/21/2023

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

11/01/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/13/2023

DOCK

ASSIGNED TO EXAMINER

10/03/2023

MDSM

NOTICE OF DESIGN SEARCH CODE E-MAILED

07/13/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

07/12/2023

NWAP

NEW APPLICATION ENTERED

06/12/2023

Continuous trademark protection

Get notified about every new filing that threatens WUXIHIGH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.